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Abstract Microglia, the brain’s innate immune cells, have highly motile processes which 
constantly survey the brain to detect infection, remove dying cells and prune synapses during 
brain development. ATP released by tissue damage is known to attract microglial processes, 
but it is controversial whether an ambient level of ATP is needed to promote constant 
microglial surveillance in the normal brain. Applying the ATPase apyrase, an enzyme which 
hydrolyses ATP and ADP, reduces microglial process ramification and surveillance, 
suggesting that ambient ATP/ADP maintains microglial surveillance. However, attempting to 
raise the level of ATP/ADP by blocking the endogenous ecto-ATPase (termed 
NTPDase1/CD39), which also hydrolyses ATP/ADP, does not affect the cells’ ramification or 
surveillance, nor their membrane currents which respond to even small rises of extracellular 
[ATP] or [ADP] with the activation of K+ channels. This indicates a lack of detectable ambient 
ATP/ADP and ecto-ATPase activity, contradicting the results with apyrase. We resolve this 
contradiction by demonstrating that contamination of commercially-available apyrase by a 
high K+ concentration reduces ramification and surveillance by depolarising microglia. 
Exposure to the same K+ concentration (without apyrase added) reduced ramification and 
surveillance as with apyrase. Dialysis of apyrase to remove K+ retained its ATP-hydrolysing 
activity but abolished the microglial depolarisation and decrease of ramification produced by 
the undialysed enzyme. Thus, applying apyrase affects microglia by an action independent of 
ATP, and no ambient purinergic signalling is required to maintain microglial ramification and 
surveillance. These results also have implications for hundreds of prior studies that employed 
apyrase to hydrolyse ATP/ADP. 
Key words: microglia, ATP, surveillance, apyrase 
Significance statement  
ATP mediates interactions between cells in many tissues, but is particularly important for 
microglia, the brain’s immune cells, which constantly survey the brain to detect infection and 
to regulate the brain’s wiring during development. It is controversial whether the ceaseless 
movement of microglia is driven by ATP release from brain cells. We show that an enzyme 
(apyrase) widely used to manipulate ATP levels is contaminated with K+ ions which inhibit 
microglial surveillance, and that no ATP release is needed to drive microglial process 
movement. Thus, all conclusions about a role of ATP in signalling based on applying apyrase 
need re-examining, and brain immune surveillance is not regulated by ATP release.  
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\body  Introduction 
ATP-mediated signalling is present in many tissues, but is particularly important for 
microglia, the brain’s innate immune cells (1). Microglia constantly survey the brain by 
extending and retracting their processes to sense their environment (2) but also, in the case 
of sudden brain damage, promptly send out processes to quickly target and enclose the site 
of injury (3). The latter response is mediated by ATP released from the damage site activating 
microglial P2Y12 receptors (4, 5), but there is controversy over whether constant surveillance 
by microglia depends on activation of receptors by an ambient level of ATP or ADP in the 
extracellular solution. Understanding what drives surveillance is important because it enables 
microglia to detect brain damage or infection (6, 7) but also to monitor and modulate the 
functional state of synapses and neurons (8–10), to remove excessively generated synapses 
by pruning them during brain development (11, 12), and to regulate the number of neurons 
through phagocytic removal of surplus progenitor cells produced during development and 
adulthood (13, 14). 
Several studies have reported that exposure to the ATP/ADP hydrolysing enzyme 
apyrase, both in vivo or in brain slices, evokes a rapid retraction of microglial processes and 
a reduction of surveillance (3, 15–17). This implies that a tonic extracellular purinergic signal 
may be needed to maintain microglial ramification and surveillance. Such a signal would imply 
a constant release of ATP into the extracellular space around microglial cells, and hydrolysis 
via ADP into AMP and adenosine by the activity of endogenous membrane-bound ecto-
ATPases, such as the microglial-bound NTPDase-1/CD39 (18) and the less selectively 
expressed 5’-nucleotidase CD73 (reviewed in (19)). Since a rise of extracellular [ATP] acts as 
a potent danger signal in the brain, triggering a rapid immunological response, these ecto-
ATPases maintain a very low extracellular ATP concentration, in the low nanomolar range 
(20–23). This low concentration is expected to be insufficient to activate even those purinergic 
receptors which display the highest affinity, such as the microglial ADP-preferring P2Y12 
subtype with an EC50 of ~100-200 nM (24). In agreement with this, recent reports show that 
microglial surveillance and ramification are independent of P2Y12 receptor signalling (5, 25, 
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26), raising the question of how application of apyrase to lower extracellular nucleotide levels 
could affect microglial ramification and surveillance. 
Apyrase, purified from potato or recombinant organisms (27) is an ecto-ATPase which 
hydrolyses a wide range of nucleotide (N) substrates including ATP and ADP, according to 
the general reaction: NTP  NDP + Pi  NMP + 2Pi.  Ectopically applied apyrase is used 
widely to deplete endogenous nucleotides in biological preparations. Indeed, over 600 papers 
in PubMed report applying apyrase to perturb signalling mediated by extracellular ATP, on the 
assumption that this enzyme is acting by hydrolysing ATP and other nucleotides. 
 By using a combination of pharmacology, electrophysiology, ion-sensitive electrode 
measurements, protein dialysis, and two-photon and confocal microscopy of microglial cells, 
in acute hippocampal slices, we show that the apyrase-evoked reduction of microglial 
ramification and surveillance is not due to an abolition of tonic purinergic signalling. Instead, it 
is mediated by cell depolarisation produced by the high [K+] content of commercially-available 
apyrase. A similar depolarization produced by raising the extracellular [K+] ([K+]e) in the 
absence of apyrase has the same effects on ramification and surveillance, and dialysing out 
the contaminating K+ abolishes the effect of apyrase while retaining its enzymatic activity. 
These results have important implications for our understanding of what drives microglial 
surveillance, but also for all experiments investigating purinergic signalling that employ 
apyrase to lower ATP levels.  
 
Results 
Apyrase decreases microglial ramification and surveillance 
To test for an effect of putative tonic ATP-mediated signalling on microglial   
morphology, we exposed acutely-prepared P12 rat hippocampal slices to the ATP hydrolysing 
enzyme apyrase (200 U/ml, Sigma A7646 was used for all experiments except where 
indicated otherwise) for 30 min. After fixation of the tissue and immuno-labelling microglia for 
Iba-1, we quantified their process ramification by performing a 3-dimensional Sholl analysis. 
Individual microglial cells were analysed at a depth of at least 60 m below the slice surface 
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(to avoid any effects due to slicing-evoked superficial cell damage) in high-resolution confocal 
image stacks. While untreated microglial cells (control) displayed a ramified morphology with 
a large number of long and highly branched processes (Fig. 1a), microglia exposed to apyrase 
had much shorter and less complex processes, covering a markedly reduced area than their 
untreated counterparts (Fig. 1b). The Sholl analysis showed that apyrase treatment reduced 
the number of intersections of microglial processes with concentric Sholl spheres at increasing 
distances from the soma (Fig. 1c), and reduced the number of branch points and process 
terminals (Fig. 1d, e).  
To investigate how microglial surveillance is affected by apyrase exposure in real time, 
we imaged microglia in hippocampal slices using two-photon microscopy and quantified 
changes of baseline surveillance and ramification minute-by-minute (see Materials and 
Methods). Apyrase was locally applied to individual microglial cells through a pipette inserted 
into the tissue ~10-20 m away from the cell’s soma. This caused a rapid retraction of 
microglial processes (Fig. 1f) and decreased both the surveillance and ramification indices in 
a dose-dependent manner (Fig. 1g-j), whereas performing the same manipulation with 
extracellular solution in the pipette (Fig. 1g-h) had no effect (to allow local application of 
apyrase to raise its concentration around the cell significantly in this experiment, the rate of 
superfusion of extracellular solution was low, which is why the apyrase-evoked change does 
not reverse rapidly under these live imaging conditions, but recovery was seen using a 
different approach in Fig. 3m below). Thus, apyrase induces a strong and rapid loss of 
microglial processes, which would conventionally be interpreted as indicating the existence of 
a tonic extracellular purinergic signal maintaining microglial ramification and surveillance. 
In order to test this hypothesis, we next assessed whether there is a detectable ATP 
concentration in the extracellular space of brain tissue, using ATP-evoked chemi-
luminescence of firefly luciferase enzyme. This emits photons that can be detected with a 
photomultiplier (PMT), with a quantum yield of almost one photon per ATP molecule and a 
detection limit of <1 nM ATP (28, 29). Brief puffs (0.5 sec) of 1 mM ATP in extracellular solution 
produced a robust PMT-mediated current, which was greatly reduced in the presence of 100 
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U/ml apyrase (Fig. 1k, l), showing that added apyrase effectively hydrolyses extracellular ATP. 
However, when imaging the ATP-evoked signal from a hippocampal slice without any puffed 
ATP, we could not detect any difference in signal amplitude if the slice was removed (Fig. 1l, 
inset), implying (surprisingly, given the effect of apyrase described above) that the extracellular 
ATP concentration in slices is kept at a very low level, below the detection limit of this assay.  
Lack of a tonic ATP release mechanism in baseline conditions 
 To further test whether extracellular ATP may be required to keep microglia motile and 
ramified, we next performed experiments interfering with ATP metabolism in brain tissue. 
Microglia express on their surface membrane high amounts of the ecto-ATPase 
NTPDase1/CD39 (18), which hydrolyses ATP or ADP into AMP which, in turn, is hydrolysed 
into adenosine by other types of ecto-enzyme (for review see (30)). This entire ecto-
nucleotidase pathway operates very rapidly, with a half time for the conversion of ATP to 
adenosine of only ~200 msec (31). Thus, if there is an ambient level of ATP present around 
microglial cells then there needs to be a tonic release of ATP which will be constantly 
hydrolysed into ATP breakdown products. Consequently, blockade of ecto-ATPases should 
lead to an accumulation of extracellular ATP in slices (32). Microglia are very sensitive to 
increases of extracellular ATP concentration, to which they respond by activating P2Y12 
receptor-gated THIK-1 K+ channels, generating an outward K+ current which leads to a 
hyperpolarisation of their membrane (33). Puff-application of ATP (or ADP) to the slice surface 
caused a dose-dependent activation of this outward K+ current in whole-cell voltage-clamped 
microglia held at 0 mV (Fig. 2a), which evoked a hyperpolarisation in unclamped cells (Fig. 
2a, inset). Notably, even concentrations of ATP as low as 100 nM generated a clearly visible 
electrical response, emphasising that microglial cells can sense even a subtle rise of 
extracellular ATP concentration due to their expression of high affinity P2Y12 receptors (5, 24).  
Despite their sensitivity to ATP, the microglial resting membrane potential (Fig, 2b, c) 
and current (Fig. 2d, red dashed line) were not detectably affected by the application of 200 
µM ARL-67156 (Fig. 2b-d), a widely used broad-spectrum NTPDase blocker (34, 35). 
Confirming that it did block endogenous ecto-ATPases however, ARL-67156 evoked a robust 
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~60% increase of the K+ current evoked by brief puffs of ATP (Fig. 2d, e). This demonstrates 
that ARL-67156 effectively blocks the hydrolysis of exogenously applied ATP, thus 
potentiating its action, whereas no detectable turnover of ATP occurs in baseline conditions 
(Fig. 2b, c) suggesting that endogenous ATP levels are very low. 
Any rise of extracellular ATP which might occur following ecto-ATPase block is also 
expected to induce changes of microglial surveillance and ramification (16, 36). To try to detect 
this, we imaged microglial motility by two-photon microscopy as in Fig. 1. Microglial cells were 
imaged at least 60 µm below the slice surface and exhibited a ramified morphology with highly 
motile processes showing constant extensions and retractions over time (Fig. 2f). After an 
initial 20 min control period we blocked ecto-ATPases by bath-applying 200µM ARL-67156. 
However, neither microglial surveillance nor ramification (Fig. 2g-j) were affected, again 
suggesting that the extracellular ATP concentration remained unaltered, and hence that little 
ATP is being released in the slice (in the absence of tissue damage).  
In summary, chemiluminescence, electrophysiological and imaging experiments 
exclude the existence of a baseline extracellular ATP concentration high enough to drive 
microglial purinergic signalling. Thus, the apyrase-evoked decrease of microglial surveillance 
and ramification is unlikely to reflect hydrolysis of extracellular ATP. 
Apyrase depolarises microglia due to its high K+ content 
We have recently shown that microglial surveillance and ramification are regulated by 
the cell’s resting membrane voltage, which is set by the tonic activity of its K+ channels, such 
that pharmacological block or knock-out of the main microglial K+ channel (THIK-1) evokes 
depolarisation of the cell and a loss of ramification and surveillance (33). Surprisingly, 
application of apyrase to hippocampal slices evoked a strong and reversible dose-dependent 
depolarisation of current-clamped microglial cells (Fig. 3a, b). In some experiments, to prevent 
any putative purinergic signalling between microglia and their surrounding cells, we carefully 
lifted the whole-cell patch-clamped cell out of the slice while maintaining the whole-cell 
configuration (Fig. 3c). After isolating the cell from its native environment we confirmed that it 
still responded to brief puffs of ATP by generating outward K+ currents (Fig. 3c). Exposure to 
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apyrase evoked an inward membrane current at a holding potential of 0mV (Fig. 3c, arrow) 
which we will show below results from a rise in [K+]e decreasing K+ efflux occurring at 0 mV 
through tonically active potassium channels. Apyrase also diminished the ATP-evoked 
outward K+ current, which could reflect both a decrease in the driving force for K+ efflux and 
apyrase hydrolysing some of the puff-applied ATP (Fig. 3c). A detailed analysis of the effects 
apyrase has on the electrophysiology of microglia is given in the Supporting Information (Fig. 
S1). 
To test the idea that apyrase raises the extracellular [K+], we measured [K+]e using K+-
sensitive electrodes inserted into the slice. Indeed, application of apyrase to slices led to a 
dramatic rise of [K+]e (Fig. 3d), which was dose-dependent and did not require a slice to be 
present at all (Fig. 3e). Thus, the apyrase solution contained, apart from the actual enzyme, 
also high amounts of potassium. The apyrase that we tested in most of our experiments is a 
very commonly used type (catalogue number A7646) from Sigma, the largest supplier with the 
greatest varieties of different apyrase preparations extracted either from potato (the majority) 
or recombinantly expressed. A literature search revealed that the vast majority of researchers 
obtained apyrase from Sigma, most commonly the preparations A6132, A6410, A6535 and 
A7646 which vary in the apyrase units/(mg protein) and purification grades. We therefore 
compared the resulting potassium concentrations of 6 different and frequently used apyrase 
preparations made up at 100 U/ml each (in standard extracellular solution containing 2.5 mM 
[K+] in the absence of apyrase: see Materials and Methods) using a commercial blood gas 
analyser. All preparations had significantly elevated [K+] contents, which correlated roughly 
inversely with the number of units of enzyme per mg of solid preparation (Fig. 3f, g). In the 
case of two apyrase types (A6132 and A6237) [K+]e reached extremely high concentrations in 
the range of 30-40 mM [K+], even at 100 U/ml, a concentration frequently used in published 
experiments in tissue slices or in vivo (100-500 U/ml).  
Next we tested the effect of an elevated potassium concentration (raised by 20 mM, to 
a total of 22.5 mM, with [Na+] lowered correspondingly) on microglial morphology in the 
absence of any apyrase, using Sholl analysis as in Fig. 1. A 30 min exposure of slices to 22.5 
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mM [K+], which roughly equates to the [K+] present in the slices in 200 U/ml apyrase (A7646) 
(Fig. 3d, e), caused a severe de-ramification of microglial cells (Fig. 3h-j) with a strong 
reduction in the number of branch points and terminal processes (Fig. 3k, l). The morphology 
in high [K+]e almost exactly matched that seen with apyrase treatment as shown in Fig. 1, and 
led to a reduced rate of surveillance of the brain because of the smaller number of processes. 
The time course of the onset of the deramification, and of the recovery when apyrase or 
elevated [K+]e was removed, were not significantly different (Fig. 3m, 2-way ANOVA p=0.68). 
Thus, apyrase induces morphological changes in microglia by virtue of the high [K+]e it 
contains, and not via ATP depletion. 
Dialysing apyrase retains enzyme activity but abolishes effects on microglial 
ramification and hence surveillance 
To test whether there is any tonic purinergic signalling affecting microglial properties, 
which may have been masked by the high [K+] content present in the apyrase preparations, 
we removed the high [K+] by dialysis against normal extracellular solution. Using a dialysis 
membrane with a cut-off molecular weight of 2 kDa, salts and other small molecules below 
this threshold were removed, while apyrase with a molecular weight of ~45kDa was retained.  
We first verified that the dialysed apyrase depleted [ATP] as effectively as the non-
dialysed apyrase from the same batch by measuring chemiluminescence-derived signals as 
in Fig. 1k. As with the non-dialysed enzyme, dialysed apyrase greatly reduced the luciferase 
signal evoked by an ATP puff (Fig. 4a), showing that dialysis did not affect the enzymatic 
activity of the apyrase. However, 200 U/ml dialysed apyrase had no effect on the resting 
membrane potential (Fig. 4b) and did not alter the membrane current of the microglia (Fig. 
S2a-b), while the same batch of non-dialysed apyrase depolarised the cells (Fig. 4b), evoked 
an inward membrane current at 0 mV, and increased the cells’ conductance at negative 
potentials (Fig. S2a-b; see Supporting Information for detailed analysis). This clearly 
demonstrates that [K+] has been effectively removed from the apyrase preparation and 
furthermore indicates that no tonic ATP levels are present and necessary to maintain the 
resting potential of microglial cells.  
10 
 
Finally, we investigated the effect of dialysed apyrase, which should lower the 
extracellular ATP concentration without raising [K+]e, on microglial morphology, using Sholl 
analysis. Strikingly, microglial cells remained as ramified as under untreated control conditions 
when exposed to 200 U/ml dialysed apyrase (Fig. 4c, d, f), while 200 U/ml of the non-dialysed 
enzyme induced the expected decrease in process ramification (Fig. 4e-f). Thus, all the effects 
of undialysed apyrase on microglial ramification, and hence on surveillance which is reduced 
when there are less processes, are produced by the high [K+] present in this product and not 
by ATP depletion.  
 
Discussion 
Microglial ramification and process movement are critical for normal brain function, 
since they underpin the ability of these cells to constantly survey the brain. This surveillance 
is thought to allow the cells not only to detect invading microorganisms, but also to prune 
redundant synapses during development and to regulate neuronal activity. It has been 
suggested that microglial surveillance may require tonic ATP-evoked signalling in microglia, 
in part on the basis of experiments lowering the extracellular ATP concentration by applying 
the ATPase apyrase, which we now show is contaminated by K+ ions which will depolarise the 
microglia. Using dialysed, purified apyrase allowed us to investigate the role of endogenous 
nucleotides in regulating microglial surveillance and morphology, without a superimposed 
elevation of external [K+] which may generate effects independent of purinergic signalling.  
Our findings show that microglial cells do not receive any tonic purinergic input that is 
required to maintain their morphology and constant surveillance in the healthy brain. 
Surprisingly, the reduced ramification and surveillance evoked by apyrase that we and others 
have observed are not due to its enzymatic activity, but are produced by the high [K+] content 
present in commercially-available apyrase preparations, which causes a significant 
depolarisation of the cells. We have recently shown that such a depolarisation is sufficient to 
dramatically reduce microglial ramification and surveillance, which are regulated and 
maintained by the cell’s resting potential, which is set by the tonic activity of the cells’ K+ 
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channels (33). Fig. 3h-m shows the direct effect of depolarisation by high [K+]e on hippocampal 
microglial morphology (since microglia may vary in their properties according to brain region 
(37), the magnitude of the effect of depolarisation on microglial morphology may vary between 
brain regions). The rise of [K+]e to ~60 mM that occurs during the spreading depression 
associated with migraine, stroke, sub-arachnoid haemorrhage or brain injury (38), or the 
anoxic depolarisation induced by ischaemia (39), and the 10 mM [K+]e rise occurring during 
synchronous high frequency activity of neurons in epilepsy (39), are expected to depolarise 
microglia and decrease their ramification and surveillance. In contrast, the [K+]e rise occurring 
during normal neuronal activity (~1 mM: 39) is much smaller and will have little effect. 
Non-activated microglial cells selectively express Gi-protein coupled P2Y12 receptors 
(5, 40), which exhibit a very high affinity for adenosine nucleotides, with an EC50 value for ADP 
in the range of ~100 nM (24). In addition, these receptors are linked to the activation of 
microglial K+ channels (33), hence making the P2Y12-K+ channel signalling complex an ideal 
sensor to translate even subtle rises of ATP or ADP concentration into an electrical signal or 
other downstream messengers. It was not surprising, then, that several studies reported that 
microglial morphology and surveillance are regulated by a tonic purinergic input that is 
essential for keeping the cells ramified and motile. These conclusions were obtained (see Fig. 
5) by applying exogenous apyrase (3, 15–17), or knocking out the endogenous ecto-ATPase 
(NTPDase1/CD39) (18, 41), in order to manipulate the extracellular nucleotide levels 
produced by any tonic nucleotide release that does occur. However, our results show that 
non-activated microglia receive no tonic purinergic input to maintain their ramification and 
surveillance, since application of dialysed, [K+]-free apyrase evoked neither a change of their 
membrane currents nor of their morphology, indicating a lack of a tonic activation of microglial 
purinergic receptors. Consistent with our results, experiments with P2Y12 receptors blocked or 
knocked out, which abolished microglial process outgrowth in response to a sudden rise of 
[ATP]e, had no effect on microglial surveillance, ramification or membrane potential (5, 25, 26, 
33).  
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Since a rise of extracellular nucleotides is recognised as a potent danger signal by 
microglia, tonic levels of ATP or ADP are normally kept very low (21–23, 42–44) and our data 
suggest that they are not sufficient to tonically activate P2Y12 receptors. Only when 
extracellular [ATP] and [ADP] rise significantly, e.g. due to brain damage, are P2Y12 receptors 
effectively activated, in order to mediate rapid process extension to the site of injury (ATP 
leakage). This targeted motility depends on ecto-ATPases, since their inhibition with ARL-
67156 abolishes the outgrowth of microglial processes to an ATP source (36, 45). This may 
involve the generation of ADP from ATP, to activate P2Y12 receptors, but could also involve 
ecto-ATPase mediated generation of adenosine which acts on microglial A3-type adenosine 
receptors (41, 45, 46). Thus, ecto-ATPase regulation of extracellular nucleotide levels is 
important for targeted microglial motility evoked by a rise of extracellular ATP levels, but 
whether ecto-ATPases also contribute to microglial physiology in resting conditions, in the 
absence of any brain damage-derived ATP release, is more controversial.  
 Our results show that blocking ecto-ATPases (with ARL-67156) in resting conditions 
caused no changes of microglial ramification and surveillance, and did not evoke a P2Y12 
receptor-evoked electrical response in patch-clamped microglial cells. In contrast to our 
finding, Matyash et al. (41) have found that microglial cells were less ramified when NTPDase1 
(CD39) is knocked out, suggesting that constitutive ATP/ADP breakdown by NTPDase1 and 
tonic activity of P2Y12 and adenosine receptors are required to maintain a ramified microglial 
morphology. However, in these studies NTPDase1 was globally knocked-out and the effects 
on microglial morphology of a direct, pharmacological inhibition or microglial-specific knock-
out were not tested. This is important, since NTPDase1-mediated effects can also originate 
from other cells (47). NTPDase1 is also prominently expressed at the surface of vascular 
smooth muscle cells (18, 40), where it contributes to the regulation of vascular tone and 
modulates vascular inflammation and thrombosis (48–50). Since microglial cells are in 
constant, bi-directional communication with blood vessels and endothelial cells (51, 52), the 
less ramified morphology observed in NTPDase1 KO animals may be the result of a primed 
or chronically activated phenotype originating from an altered micro-environment around blood 
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vessels. Furthermore, NTPDase1 exhibits functions beyond its enzymatic activity by 
interacting with Ran Binding Protein M (RanBPM) through its cytoplasmic N-terminal domain 
(53). RanBPM is ubiquitously expressed in the brain and acts as an intracellular signalling hub 
for a variety of signalling proteins including surface β-integrins (54), which regulate microglial 
morphology and process dynamics (55, 56). Conceivably, knock-out of NTPDase1 may cause 
microglial de-ramification by interrupting RanBPM-signalling, independent of any changes in 
purinergic signalling. Further evidence for a lack of tonic ATP release and NTPDase1 activity 
under physiological conditions is the finding that extracellular adenosine levels are not 
generated by NTPDase-mediated ATP hydrolysis, but mainly result from a direct release of 
adenosine from cells (57).  
 A key outcome of our study is that, surprisingly, all apyrase preparations that we tested, 
which are commonly used by researchers, were contaminated by a high [K+] content, which 
presumably arises from the process by which the apyrase is manufactured. Sigma-Aldrich is 
by far the most popular supplier of apyrase preparations for scientists. A Google scholar 
search using the search terms “apyrase Axxxx” revealed the following number of publications 
for different Sigma-Aldrich apyrase types: A6132 – 68, A6535 – 97, A7646 – 33, A6410 – 58 
(though most publications list only the supplier’s name without the catalogue number). In 
experiments performed on brain slices and in vivo, apyrase is commonly used at 
concentrations of 100-300 U/ml (500 U/ml is the maximum), which corresponds to a rise of 
extracellular [K+] in the range of 5 to >80mM.  
 Apyrase is commonly used in neurobiological studies due to the widespread role of 
ATP as a neurotransmitter (58). Using the search terms “apyrase neuron” in NCBI/PubMed 
results in 111 publications, whereas “apyrase glia” gives 83 hits, of which the majority studied 
astrocytes (57 papers) and microglia (27 papers). For instance, in the astrocyte field, apyrase 
has been used in brain slices, retinal explants (ex vivo) or in vivo at higher doses between 25-
300 U/ml to investigate the ATP dependence of astroglial calcium signalling (59, 60), the 
mechanisms of ATP release from astrocytes (61–63), or astrocyte-neuron communication 
(64–66). Similarly for microglia, apyrase-induced depletion of extracellular purines in brain 
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slices or in vivo has been used to investigate the role of extracellular ATP in (i) microglial 
baseline surveillance and targeted motility to focal tissue damage or an ATP source (3, 15–
17, 25, 62, 67–69), (ii) microglial-astrocyte communication (3, 60, 70), (iii) ischaemia-induced 
microglial death (71) and (iv) hypotonia-evoked microglial ATP release (72). Without 
questioning the conclusions of these studies, which usually reflect evidence from a number of 
different experimental approaches, the fact that undialysed apyrase can strongly depolarise 
cells due to its accompanying [K+] content makes it essential to re-assess some of the results 
obtained, particularly from experiments using a higher dose of apyrase. Protein dialysis 
provides a simple and effective way to remove the unwanted K+ from apyrase while retaining 
its enzymatic activity, and we strongly advocate this procedure for any further studies using 
apyrase.  
 In conclusion, our study demonstrates that the extracellular ATP concentration in 
healthy brain tissue is not sufficient to drive tonic purinergic signalling in microglia, which is 
hence not required to maintain their surveillance and ramification under non-activated “resting” 
conditions.  
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Materials and Methods 
Brain slice preparation 
Animal procedures were carried out in accordance with the guidelines of the UK 
Animals (Scientific Procedures) Act 1986 and subsequent amendments. Acute hippocampal 
slices (300 µm thick, see schematic in Fig. 1k) were prepared (73) from P12 Sprague-Dawley 
rats of either sex, in ice-cold solution containing (mM) 124 NaCl, 26 NaHCO3, 1 NaH2PO4, 2.5 
KCl, 2 MgCl2, 2 CaCl2, 10 glucose, bubbled with 95% O2/5% CO2, pH 7.4, as well as 1 mM 
Na-kynurenate to block glutamate receptors. Brain slicing does not activate microglia for at 
least 4 hours, as judged by cell morphology, motility and interleukin 1β release (74, 75), and 
allows pharmacological investigation of mechanisms in a manner that is not possible using in 
vivo experiments. Supporting  this, surveillance and ramification of microglia were essentially 
constant during imaging for up to an hour in brain slices (Fig. 3D of ref. 33; Fig. 1g-h) while in 
contrast the microglia would retract their processes and decrease surveillance if they were 
becoming activated. Slices were incubated for 30 min in darkness at room temperature (22–
24°C) in oxygenated HEPES-buffered external solution (see below) containing 25 µg/ml Alexa 
594 conjugated isolectin B4 (ThermoFisher) for all experiments involving live imaging or 25 
µg/ml Alexa 568 conjugated isolectin B4 for electrophysiology experiments (74, 76), before 
being used in experiments. Isolectin B4 labelling does not activate microglia (76) and its use 
avoids functional changes which might occur in transgenically-labelled microglia. 
Solutions and electrophysiology 
Slices were superfused with HEPES-buffered solution, at 34-36oC for all experiments 
involving imaging and at room temperature (22-24oC) for electrophysiological experiments, 
containing (mM) 140 NaCl, 2.5 KCl, 10 HEPES, 1 NaH2PO4, 2 CaCl2, 1 MgCl2, 10 glucose, 
pH set to 7.4 with NaOH, bubbled with 100% O2. When the [KCl] was raised by 20 mM, [NaCl] 
was lowered by 20 mM. Cells were whole-cell clamped with electrodes containing KCl based 
solution, comprising (mM) 125 KCl (or CsCl), 4 NaCl, 1 CaCl2, 10 HEPES, 10 EGTA, 4 
MgATP, 0.5 Na2GTP, pH set to 7.1 with KOH or CsOH. The final osmolarity was 285±5 
mOsmol/kg. Microglia were identified by their fluorescent label and ramified morphology, and 
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whole-cell clamped at a depth of ~50-100 µm in the slice using borosilicate pipettes with a tip 
resistance of ~4-5 MΩ, giving a series resistance of <20 MΩ. Electrode junction potentials 
were compensated. I-V relations were from responses to 200 msec voltage steps ranging from 
-120 mV to +60 mV in 30 mV increments. Voltage- and current-clamp recordings were 
performed using a MultiClamp 700B amplifier (Molecular Devices). Currents were filtered at 1 
kHz, digitized (10 kHz) and analysed off-line using pClamp10 software. 
Drugs and dialysis 
 Drugs were obtained from Sigma-Aldrich or Tocris, and in live-imaging or 
electrophysiological experiments were applied via the bath perfusion (ARL-67156, BaCl2) or 
locally via pressure ejection from a puffing pipette placed at the slice surface (in the case of 
ATP). Apyrase was applied either directly as a bolus to the perfusion chamber with the flow 
temporarily stopped (in electrophysiological experiments) or added to a patch pipette inserted 
into the slice tissue and puffed onto an individual microglial cell that was real-time imaged (Fig. 
1f-j).  
Dialysis of apyrase was performed using a 3 ml dialysis cassette (Slide-A—Lyzer, 
Thermo Scientific, 2 kDa MWCO, Cat. No. 87718) placed in cold dialysis buffer (HEPES-
buffered extracellular solution) with 300x the sample volume for 2 hours at 4°C. The dialysis 
buffer was stirred and changed after 1 hour. 
Chemiluminescence assay 
 ATP was measured with a luciferin/luciferase-based chemiluminescence assay which 
is specific for the detection of ATP. Superfusion of brain slices was halted and aliquots 
containing 25 µl of luciferin stock (Sigma L9506; 12 mg/ml in extracellular solution) and 25 µl 
of luciferase stock (Applichem A1006; 6 mg/ml in 0.5 M Tris buffer, pH 7.5) were added to a 
total bath chamber volume of ~0.5 ml at room temperature (as luciferase is not stable at higher 
temperatures). ATP-derived bioluminescence was detected using a photomultiplier tube 
(Thorn EMI Electronics 9224B, input voltage set to 1000 V) in darkness. This system is able 
to detect 6.2 x 10-11 M ATP (29). Photo-electrical currents were amplified, digitized and 
recorded using pClamp10.  
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Potassium measurements 
 Measurements of [K+]e in experiments on brain slices were performed using custom-
made potassium-sensitive electrodes fabricated and calibrated as described (77).  
 The [K+] in extracellular solution (without a slice) to which different apyrase 
preparations were added (at 100 U/ml) was also measured using a blood-gas analyser 
(Siemens RapidLab 348EX) set to dialysis mode. The inbuilt potassium sensor was calibrated 
according to the manufacturer’s instructions and measurements were interleaved with control 
extracellular solution containing a preset potassium concentration. Values in Fig. 3f refer to 
the total [K+] including the 2.5 mM KCl of the standard extracellular solution. 
Two-photon imaging 
 Microglia in hippocampal slices were imaged at 34-36oC, at a depth of ~50-100 µm in 
the slice (to avoid studying superficial microglia that had started to become activated by the 
slicing procedure) using a Zeiss LSM 710 microscope (with a 20X lens, NA 1.0) and a 
Spectraphysics Mai Tai DeepSee eHP Ti:sapphire infrared laser. For imaging of microglia 
labelled with isolectin B4-Alexa 594, the laser was tuned to a wavelength of 800 nm; generally 
the laser was adjusted to 1.8-2% of its maximum power, corresponding to ~5 mW at the 
preparation. The pixel dwell time was 1 µsec. For imaging of microglial surveillance, stacks of 
21-31 slices imaged at 2 µm depth intervals were acquired every 60 sec. Images were typically 
512 by 512 pixels and covered a square field of view 200 to 250 µm wide.  
Image analysis 
Analysis of two-photon images was performed using custom-written ImageJ (NIH) and 
MATLAB scripts (The MathWorks, Inc.), available at https://github.com/AttwellLab/Microglia. 
For analysis and quantification of microglial surveillance, each slice of every stack was filtered 
with a median filter after subtraction of smooth continuous background with the ImageJ 
‘subtract background’ plugin with a ball size of 30 pixels. The 4D stacks were then registered 
first for lateral drift, then rotated 90° on their side, registered for z-drift and rotated back to their 
original orientation. We then performed a maximum intensity projection. Cells of interest were 
individually selected by manually drawing a region of interest (ROI) around an area including 
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all their process extensions over the whole duration of the resulting 2D movie, and erasing 
data around that ROI. These 2D movies of individual cells were then manually binarised and 
saved as independent files. 
To quantify surveillance, for each movie, starting with the second frame, we subtracted 
from each binarised frame Ft the preceding frame Ft-1 and created two binarised movies, PE 
consisting of only the pixels containing process extensions (Ft-Ft-1 > 0) and PR consisting of 
only the pixels containing process retractions (Ft-Ft-1 < 0). In both PE and PR, all other pixels 
are set to 0. The baseline surveillance index B is defined as the sum over all non-zero pixels 
in PE + PR normalised by its average over the initial 20 minutes of each experiment, i.e.: 
B = (Σpixels PE+PR)/<(Σpixels PE+PR)>control 
where Σpixels denotes a sum taken over all non-zero pixels and < >control denotes a temporal 
average taken over the control period of the experiment (the first twenty minutes here). 
Surveillance indices were calculated as absolute values according to B = (Σpixels PE+PR), and 
subsequently normalised to the control condition. The surveillance index provides a measure 
of the brain volume that is surveyed by a microglial cell in a given time. It is affected both by 
the rate at which processes elongate and shorten, and by the overall number of the microglial 
processes and their length.  
To quantify ramification, in each movie frame, the MATLAB functions bwarea 
(uk.mathworks.com/help/images/ref/bwarea.html) and bwperim with 8-connected 
neighbourhood (uk.mathworks.com/help/images/ref/bwperim.html) were used to quantify 
respectively the area and the perimeter of the cell. The ramification index R is defined as the 
ratio of the perimeter to the area, normalised by that same ratio calculated for a circle of the 
same area. Specifically: 
R = (perimeter/area) / [2.(π/area)1/2].  
Thus, R = 1 if the cell is a perfect circle. The more ramified the cell, the larger R is. In 134 cells 
in hippocampal slices the mean value of R was 6.44±0.14 at the beginning of the experiment.  
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Sholl analysis 
Microglial morphology was also assessed by Sholl analysis (78). Rat hippocampal 
brain slices were prepared as described above. After a 30 min recovery, slices were incubated 
at room temperature in oxygenated extracellular solution containing 100 or 200 U/ml apyrase 
(A7646) or 22.5 mM [K+]e for 30 mins (for Figs. 1a-e and 3j-l) or (for Fig. 3m) for 7.5 and 15 
mins followed by a further 15 mins in solution without added apyrase or 22.5 mM [K+]e to 
observe recovery from the effects of apyrase and K+. Tissue sections were then fixed in 4% 
paraformaldehyde for 45 minutes. After washing 3 times for 15 mins in PBS slices were 
blocked and permeabilized in 10% normal goat serum and 0.25% Triton X-100 in PBS for 4 
hours at room temperature and then incubated at 4°C overnight in rabbit anti-Iba1 (Synaptic 
Systems, Cat. No. 234003, at 1:500) antibody prepared in blocking solution. After washing 3 
times for 20mins in PBS, slices were incubated overnight in secondary antibody (goat anti-
rabbit Alexa 543, Invitrogen, at 1:500). Slices were then washed in PBS, incubated in DAPI 
(Invitrogen) and mounted on glass slides using DAKO fluorescence mounting medium. Z-
stacks of individual microglial cells located at ~60 µm below the slice surface were acquired 
at 0.3 µm depth intervals using a 63X oil immersion objective (NA 1.4) on a Zeiss LSM700 
confocal microscope. Image stacks were pre-processed in ImageJ by median filtering 
(‘despeckling’) after subtraction of smooth continuous background with a ball size of 30 pixels 
and saved as TIF files. Reconstructions of individual microglial cells were carried out using 3D 
automatic cell tracing in Vaa3D software (www.vaa3d.org). Morphological parameters were 
then extracted using custom code written in MATLAB. The software used is available at 
https://github.com/AttwellLab/Microglia. 
Statistics 
 Data are presented as mean+s.e.m. P values are from two tailed Student’s t-tests (for 
normally distributed data) or Mann-Whitney U tests (for non-normally distributed data). 
Normality of data was checked using the Kolmogorov-Smirnov or Shapiro-Wilk test and 
equality of variance confirmed using the F-test. Sholl analysis distributions were compared 
with a Kolmogorov-Smirnov test. For multiple comparisons, p values are corrected using a 
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procedure equivalent to the Holm-Bonferroni method (for N comparisons, the most significant 
p value is multiplied by N, the 2nd most significant by N-1, the 3rd most significant by N-2, 
etc.; corrected p values are significant if they are less than 0.05). 
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Figure Legends 
Figure 1. Apyrase reduces microglial ramification and surveillance. 
a-b Specimen images (left) and skeletonised arbours (right) of rat hippocampal microglia 
labelled with antibody to Iba-1 after superfusion with (a) control solution and (b) solution 
containing 200 U/ml apyrase (Sigma A7646). c-e 3D Sholl analysis derived values of number 
of process intersections with spherical shells at different distances from the soma (c, control 
and 200 U/ml curves differ significantly, p=0.0058), number of cell branch points (d), and 
number of process ends (e) for microglia in control solution or solution containing 100 or 200 
U/ml apyrase. Number of cells on bars. f-j Effect of apyrase on microglial surveillance and 
ramification. f Colour coded superimposed images at 15 and 20 mins in control solution (top) 
and at 35 and 40 mins after starting apyrase superfusion at t=20 min (bottom; green, process 
extensions; red, process retractions; yellow, no change). g-h Plots of surveillance index (g) 
and ramification index (h) against time when individual microglia are exposed to apyrase (via 
a puffing pipette inserted into the slice). Control data (grey) show experiments with the puffing 
pipette filled with extracellular solution. i-j Surveillance index (i, see Materials and Methods) 
and ramification index (j) in control solution, and 100 and 200 U/ml apyrase. k Luciferin-
luciferase luminescence (PMT current, arbitrary units, AU) evoked by ATP puff in control 
solution and solution containing apyrase (without a slice) illustrating that apyrase effectively 
degrades the puffed ATP (inset schematic shows experimental set-up, with blue showing the 
hippocampal stratum radiatum). l Mean luciferin-luciferase signal evoked by puffing 1 mM ATP 
onto a slice in the absence and presence of 100 U/ml apyrase (as in k), generated by a slice 
with no puffed ATP, and the baseline signal generated in the absence of a slice (con); inset 
shows records for the last two conditions with dashed line showing no signal. 
Figure 2. Tonic ATP release does not maintain microglial surveillance & ramification. 
a Current response of microglial cell clamped to 0 mV to puffed ATP (black boxes). Inset 
shows membrane potential response in an unclamped cell. b-c Inhibition of ecto-ATPases 
with ARL-67156 has no effect on microglial membrane potential (b specimen trace, c mean 
data, number of cells on bars). d Ecto-ATPase inhibition potentiates current response at 0 mV 
29 
 
to puffed ATP (black squares), but does not alter baseline current (red dashed line). e Mean 
normalised data for current evoked by puffed ATP in experiments like d, in the absence and 
presence of ARL-67156. f-j Effect of ecto-ATPase inhibition on microglial surveillance and 
ramification. f Colour coded superimposed images (as in Fig. 1f) at 5 and 10 mins in control 
solution (top) and at 35 and 40 mins (bottom) after starting ARL-67156 superfusion at t=20 
min. (g-h) Time course of surveillance index (g) and ramification index (h) before and during 
superfusion of ARL-67156. i-j Mean normalised surveillance index (i) and ramification index 
(j) during superfusion of ARL-67156.  
Figure 3. Apyrase depolarises microglia due to K+ contamination. 
a Microglial membrane potential depolarisation during superfusion of apyrase. b Mean 
membrane potential for microglia in control solution and in solution with 100 or 200 U/ml 
apyrase (Sigma A7646) added. Number of cells on bars; p values from t-tests are for 
comparison with control solution. c Effect of apyrase (Sigma A7646) on baseline membrane 
current at 0 mV of a microglial cell pulled out of the slice (apyrase evokes an inward current, 
shaded red) and on the response to puffed ATP (black squares, upward current deflections). 
d Specimen trace for measuring [K+]e with a K+-sensitive electrode in a slice during application 
of apyrase (Sigma A7646). e Mean [K+]e measurements (as in d) when applying 100 U/ml 
apyrase (Sigma A7646) with no slice present or in a slice, or applying 200 U/ml apyrase to a 
slice. f [K+]e measured with a blood gas analyser in extracellular solution to which different 
apyrase preparations were added at 100 U/ml (abscissa shows Sigma-Aldrich catalogue 
numbers); values include the 2.5 mM K+ in the extracellular solution recipe. g Plot of [K+]e 
(ordinate) in extracellular solution containing 100 U/ml apyrase made up from sources of 
different purity (abscissa). h-I Specimen images (left) and skeletonised arbours (right) of rat 
hippocampal slice microglia labelled with antibody to Iba-1 after incubation with (h) control 
solution and (i) solution containing 22.5 mM K+ for 30 mins (see Materials and Methods for 
details). j-l Sholl analysis derived values of number of process intersections with spherical 
shells at different distances from the soma (j, control and 22.5 mM [K+]e curves differ 
significantly, p=2.4x10-4), number of cell branch points (k), and number of process ends (l) for 
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slices exposed to control solution or solution containing 22.5 mM [K+]e (numbers of cells on 
bars). m Sholl analysis derived number of process ends (reflecting microglial ramification) 
after different times of exposure to 22.5 mM [K+]e or 200 U/ml apyrase, and after 15 min 
washout, show a similar magnitude and time course of de-ramification and recovery for both 
conditions (p=0.68, 2-way ANOVA). 
Figure 4. Dialysing apyrase retains microglial membrane potential and morphology. 
a The luciferin-luciferase PMT signal evoked by puffing ATP in extracellular solution (without 
a slice) is reduced by the same amount by dialysed and undialysed apyrase. b Resting 
potential of microglia in normal extracellular solution (con), solution with 100 U/ml dialysed 
apyrase added (Sigma A7646), and solution with 100 U/ml undialysed apyrase added (as in 
Fig. 3b). Number of cells on bars. c-e Specimen images (left) and skeletonised arbours (right) 
of rat hippocampal slice microglia labelled with antibody to Iba-1 after incubation with (c) 
control solution, (d) solution containing dialysed apyrase (200 U/ml apyrase, Sigma A7646), 
and (e) solution containing non-dialysed apyrase. f 3D Sholl analysis derived values of number 
of process intersections with spherical shells at different distances from the soma for microglia 
superfused with solutions in c-e. Control and non-dialysed apyrase curves differ significantly, 
p=2.9x10-3, whereas no difference exists between control and dialysed apyrase, p=0.91. 
Figure 5. Regulation of adenine nucleotide levels and microglial membrane potential. 
Left (green box): Tonic activity of K+ channels generates a K+ efflux (green arrow) which 
maintains the resting potential of microglia, which is essential for the normal ramification of 
microglia and hence their normal level of surveillance. Middle (red box): Tissue damage 
releases ATP. Endogenous ecto-ATPases on microglia and other brain cells hydrolyse ATP 
to ADP, and ADP to AMP (diagram shows ecto-ATPase only on microglia for simplicity). ADP, 
and possibly ATP, can activate P2Y12 receptors on microglia. In the case of tissue damage 
this evokes process outgrowth (chemotaxis) to the damaged area. P2Y12 activation also 
increases the activity of microglial K+ channels (Fig. 2a), allowing P2Y12 receptors to be used 
to sense the baseline level of ATP/ADP (as in Fig. 2). If there is tonic ATP release in 
physiological conditions, blocking ecto-ATPases with ARL-67156 will elevate extracellular 
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[ATP] and [ADP] and generate a membrane current. Figure 2d (baseline current) shows that 
no such current is generated, implying that there is no detectable tonic activation of P2Y12 
receptors. Right (blue box): Adding exogenous apyrase contaminated with K+ raises [K+]e 
artefactually and thus decreases the outward current through K+ channels (shown as an 
inward shift of current: orange arrow), depolarising the microglia and decreasing ramification 
and surveillance. Adding apyrase (dialysed or undialysed) will also lower the extracellular level 
of ATP and ADP, as demonstrated in Figs. 1k and 4a.  
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